Growth Metrics

Enovis (ENOV) Net Cash Flow Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -53.07%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 17.60%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -562.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -283.58%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -564.44%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 76.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -31.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -394.13%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 57.36%
10 Enovis 1.25 Bn 1.22 Bn 365.49 Mn 71.43%

Historic Data

Download Data 🔒
DateValue
Apr 3, 2026 71.43%
Dec 31, 2025 -74.55%
Oct 3, 2025 -107.32%
Jul 4, 2025 113.53%
Apr 4, 2025 -135.77%
Dec 31, 2024 -12.39%
Sep 27, 2024 -2,568.97%
Jun 28, 2024 -389.78%
Mar 29, 2024 1,356.87%
Dec 31, 2023 137.67%
Sep 29, 2023 100.51%
Jun 30, 2023 101.89%
Mar 31, 2023 95.98%
Dec 31, 2022 -105.79%
Sep 30, 2022 -134.72%
Jul 1, 2022 19.43%
Apr 1, 2022 -109.10%
Dec 31, 2021 1,606.86%
Oct 1, 2021 19,157.40%
Jul 2, 2021 -132.90%
Apr 2, 2021 151.42%
Dec 31, 2020 153.62%
Oct 2, 2020 101.11%
Jul 3, 2020 -1,920.58%
Apr 3, 2020 6,433.60%
Dec 31, 2019 -47.17%
Sep 27, 2019 -246.95%
Jun 28, 2019 -204.73%
Mar 29, 2019 -714.14%
Dec 31, 2018 -166.95%
Sep 28, 2018 7,848.48%
Jun 29, 2018 -76.82%
Mar 30, 2018 103.65%
Dec 31, 2017 -146.11%
Sep 29, 2017 -85.92%
Jun 30, 2017 654.22%
Mar 31, 2017 -260.25%
Dec 31, 2016 247.09%
Sep 30, 2016 -90.56%
Jul 1, 2016 -333.02%
Apr 1, 2016 93.89%
Dec 31, 2015 -188.65%
Sep 25, 2015 208.85%
Jun 26, 2015 98.35%
Mar 27, 2015 -150.38%
Dec 31, 2014 107.73%
Sep 26, 2014 -168.70%
Jun 27, 2014 -142.80%
Mar 28, 2014 169.21%
Dec 31, 2013 -676.35%
Sep 27, 2013 297.95%
Jun 28, 2013 2,083.15%
Mar 29, 2013 -148.42%
Dec 31, 2012 -352.23%
Sep 28, 2012 -711.43%
Jun 29, 2012 -203.08%
Mar 30, 2012 2,846.53%
Dec 31, 2011 -17.79%
Sep 30, 2011 115.10%